Quarterly report pursuant to Section 13 or 15(d)

Equity (Summary Of Non-Vested Restricted Stock And Restricted Stock Units) (Details)

v3.23.1
Equity (Summary Of Non-Vested Restricted Stock And Restricted Stock Units) (Details) - Restricted Stock [Member] - $ / shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Unvested balance outstanding, beginning of period 889,327 460,470
Granted 318,811 208,035
Vested (38,670)  
Unvested balance outstanding, end of period 1,169,468 668,505
Weighted Average Grant Date Fair Value, Beginning Balance $ 22.06 $ 20.72
Weighted Average Grant Date Fair Value, Granted 27.99 29.80
Per Share Weighted Average Grant Date Fair Value, Vested 29.80  
Per Share Weighted Average Grant Date Fair Value, Ending Balance $ 23.42 $ 23.56
Available for grant 791,862 1,331,495